This finding is similar to earlier cellular studies that showed magnolol promotes cancer cell migration and invasion by reducing the NF-κB signaling pathway and MMP activity in breast cell lines and cholangiocarcinoma, respectively [54]. Here, NFKB1 is linked to cancer.